J. MATTHEW SINGLETON - Director at Viking Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
VKTX on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by J. MATTHEW SINGLETON since 10 Mar 2025

Holdings reported by J. MATTHEW SINGLETON for Viking Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, par value $0.00001 per share 12,650 $470,706 $37.21 02 Jan 2026 Direct
Stock Option (Right to Buy) 20,400 02 Jan 2026 Direct Common Stock

Transactions reported by J. MATTHEW SINGLETON for Viking Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.